Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Alternative platelet differentiation pathways initiated by nonhierarchically related hematopoietic stem cells.

Carrelha J. et al, (2024), Nat Immunol, 25, 1007 - 1019

Rapamycin Treatment Reduces Brain Pericyte Constriction in Ischemic Stroke

Beard D. et al, (2024)

A Multiomic Single-Cell Atlas of Human Myelopoiesis Reveals Cellular and Molecular Drivers of Immunomodulatory Drug-Induced Neutropenia

Simoglou Karali C. et al, (2023), Blood, 142, 935 - 935

Cooperation between SF3B1 and JAK2V617F Mutations Accelerates Fibrotic Progression in Myeloproliferative Neoplasms By Enhancing STAT1 Signaling

O Sullivan J. et al, (2023), Blood, 142, 861 - 861

Platelet-Restricted Clonal Hematopoiesis

Sousos N. et al, (2023), Blood, 142, 814 - 814

Platelets Sequester Extracellular DNA, Capturing Tumour-Derived and Free Fetal DNA

Murphy L. et al, (2023), Blood, 142, 277 - 277

Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies.

Khan AO. et al, (2023), Cancer Discov, 13, 364 - 385

A pro-inflammatory stem cell niche drives myelofibrosis through a targetable galectin 1 axis

Li R. et al, (2023)

Modelling the pathology and treatment of cardiac fibrosis in vascularised atrial and ventricular cardiac microtissues.

Reyat JS. et al, (2023), Front Cardiovasc Med, 10

Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy.

Evans JS. et al, (2022), Eur J Cancer, 176, 110 - 120

Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19.

Kotanidis CP. et al, (2022), Lancet Digit Health, 4, e705 - e716

In utero origin of myelofibrosis presenting in adult monozygotic twins.

Sousos N. et al, (2022), Nat Med, 28, 1207 - 1211

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.

COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk None. and COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None., (2022), Cell, 185, 916 - 938.e58

Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein.

Munoz Pinto MF. et al, (2022), Neuro Oncol, 24, 52 - 63

Cross-Talk between Hematopoietic Cells and Fibroblast Subsets Drives Inflammation and Remodelling of the Bone Marrow Microenvironment in Myeloproliferative Neoplasms

Li R. et al, (2022), BLOOD, 140, 1091 - 1092

Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.

Chowdhury O. et al, (2021), Br J Haematol, 194, 1010 - 1015

A novel molecular magnetic resonance imaging agent targeting activated leukocyte cell adhesion molecule as demonstrated in mouse brain metastasis models.

Zarghami N. et al, (2021), J Cereb Blood Flow Metab, 41, 1592 - 1607

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None. et al, (2021)

A BRAIN METASTASIS THERAPY TWEAK, FOR THE BETTER? CONCOMITANT STEREOTACTIC RADIOTHERAPY & MOLECULAR-TARGETED THERAPY

Sarmiento M. et al, (2017), NEURO-ONCOLOGY, 19, 126 - 126

PP02. TOWARDS TNF TYPE-1 RECEPTOR SPECIFIC PERMEABILISATION OF THE BLOOD-BRAIN BARRIER IN BRAIN METASTASIS

Karali MCS. et al, (2017), Neuro-Oncology, 19, i1 - i1

Load More

Include forthcoming?